Arrowhead Pharmaceuticals (ARWR) Capital Leases (2011 - 2016)
Arrowhead Pharmaceuticals (ARWR) posted Capital Leases of $378862.0 for Q2 2016, down 12.03% on a QoQ basis from $430665.0 in Q1 2016, and down 36.38% year-over-year from $595516.0 in Q3 2015.
Arrowhead Pharmaceuticals (ARWR) Capital Leases (2011 - 2016) Analysis & Trends
Arrowhead Pharmaceuticals' Capital Leases history runs 6 years deep, the most recent figure standing at $378862.0 for Q2 2016.
- Quarterly Capital Leases fell 36.38% year-over-year to $378862.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $378862.0 (down 36.38% YoY) and the FY2015 annual result came in at $540792.0, down 28.69% from the prior year.
- Capital Leases was $378862.0 for Q2 2016 at Arrowhead Pharmaceuticals, down from $430665.0 in the prior quarter.
- Across five years, Capital Leases topped out at $1.4 million in Q1 2012 and bottomed at $378862.0 in Q2 2016.
- A 5-year average of $878776.7 and a median of $838973.0 in 2014 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2012 — Capital Leases retreated 15.0% — and 2016, when it plunged 36.38%.
- Arrowhead Pharmaceuticals' Capital Leases stood at $1.2 million in 2012, then dropped by 18.03% to $1.0 million in 2013, then dropped by 29.93% to $705173.0 in 2014, then slumped by 31.1% to $485842.0 in 2015, then fell by 22.02% to $378862.0 in 2016.
- Business Quant data shows ARWR's Capital Leases at $378862.0 in Q2 2016, $430665.0 in Q1 2016, and $485842.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 378,862.00 |
| Mar 31, 2016 | 430,665.00 |
| Dec 31, 2015 | 485,842.00 |
| Sep 30, 2015 | 540,792.00 |
| Jun 30, 2015 | 595,516.00 |
| Mar 31, 2015 | 650,014.00 |
| Dec 31, 2014 | 705,173.00 |
| Sep 30, 2014 | 758,340.00 |
| Jun 30, 2014 | 812,169.00 |
| Mar 31, 2014 | 865,777.00 |
| Dec 31, 2013 | 1.01 Mn |
| Sep 30, 2013 | 1.06 Mn |
| Jun 30, 2013 | 1.12 Mn |
| Mar 31, 2013 | 1.17 Mn |
| Dec 31, 2012 | 1.23 Mn |
| Sep 30, 2012 | 1.28 Mn |
| Jun 30, 2012 | 1.34 Mn |
| Mar 31, 2012 | 1.39 Mn |
| Dec 31, 2011 | 1.44 Mn |